PATENT CLAIM ANALYSIS

Application Number: 15940253
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["544", "276000"]

Abstract:
The present invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, pharmaceutical preparation, or pharmaceutical composition thereof, and their use for the treatment of pain, inflammatory disease, neuropathy, dermatological disorders, pulmonary conditions, and cough, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).

Claim (Index 79):
The compound of  claim 66 , wherein each of R 1 , R 2 , and R 3  is independently C 1 -C 6  alkyl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.38298
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15512213', '14956586', '13661812', '13832240', '15279576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7515697388955153
- 35 USC 102 Novelty (BERT): 0.5343511508709241
- Combined Prediction Score: 0.7298478800930561
- Mean Citation Score: 282.202844
- Max Citation Score: 331.535
- Similarity Product: 175.27120971083642

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test